Nov 13 (Reuters) - Predictive Oncology Inc :
* PREDICTIVE ONCOLOGY REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES STRATEGIC UPDATE
* PREDICTIVE ONCOLOGY INC: INITIATED A PROCESS TO EVALUATE A BROAD RANGE OF STRATEGIC ALTERNATIVES INTENDED TO MAXIMIZE SHAREHOLDER VALUE
* PREDICTIVE ONCOLOGY: POSSIBLE ALTERNATIVES CAN INCLUDE SALE OF CO, SALE OF ASSET/ASSETS, OR LICENSING TRANSACTION
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments